United States of America

7 Vaccines Approved for Use in United States of America

RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: nytimes.com
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
Approval Source: bbc.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: nytimes.com
Protein Subunit

Novavax

Nuvaxovid

Approved in 40 countries
22 trials in 14 countries
Approval Source: fda.gov
RNA

Moderna

Spikevax Bivalent Original/Omicron BA.4/BA.5

Approved in 33 countries
2 trials in 1 country
Approval Source: fda.gov
RNA

Pfizer/BioNTech

Comirnaty Bivalent Original/Omicron BA.4/BA.5

Approved in 33 countries
4 trials in 1 country
Approval Source: fda.gov
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: nytimes.com

54 in Clinical Trials in United States of America

Protein Subunit

Novavax

Nuvaxovid

Approved in 40 countries
22 trials in 14 countries
Protein Subunit

COVAXX

UB-612

7 trials in 2 countries
Protein Subunit

Sanofi/GSK

Recombinant Protein

6 trials in 7 countries
VLP

Medicago

Covifenz

Approved in 1 country
6 trials in 6 countries
DNA

Inovio

INO-4800

10 trials in 9 countries
RNA

Arcturus Therapeutics Inc

ARCT-154

6 trials in 3 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
RNA

Pfizer/BioNTech

BNT162b2s01

3 trials in 2 countries
RNA

Pfizer/BioNTech

BNT162b1

5 trials in 3 countries
RNA

Moderna

mRNA-1273.617.2

2 trials in 1 country
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
RNA

Moderna

mRNA-1273.213

2 trials in 1 country
RNA

Moderna

mRNA-1273.211

4 trials in 1 country
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Inactivated

Bharat Biotech

Covaxin

Approved in 14 countries
16 trials in 2 countries
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Protein Subunit

Kentucky Bioprocessing

KBP-201

2 trials in 1 country
RNA

Arcturus Therapeutics Inc

ARCT-165

2 trials in 2 countries
RNA

Arcturus Therapeutics Inc

LUNAR-COV19/ARCT-021

6 trials in 2 countries
RNA

Moderna

mRNA-1283

2 trials in 1 country
RNA

Moderna

mRNA-1283.211

RNA

Pfizer/BioNTech

BNT162b2 (B.1.1.7 + B.1.617.2)

RNA

Pfizer/BioNTech

BNT162b2 (B.1.1.7)

RNA

Pfizer/BioNTech

BNT162b2 (B.1.617.2)

Non Replicating Viral Vector

ImmunityBio Inc

hAd5-Covid-19

7 trials in 2 countries
Non Replicating Viral Vector

Mahidol University

NDV-HXP-S

7 trials in 3 countries
Non Replicating Viral Vector

Vaxart

VXA-CoV2-1.1-S

Replicating Viral Vector

Aivita Biomedical Inc

AV-COVID-19

4 trials in 2 countries
Replicating Viral Vector

City of Hope Medical Center

COH04S1

2 trials in 1 country
Protein Subunit

US Army Medical Research and Development Command

SpFN COVID-19 Vaccine

DNA

Providence Health & Services

CORVax12

RNA

GlaxoSmithKline

CoV2 SAM (LNP)

RNA

GlaxoSmithKline

CV2CoV

RNA

HDT Bio

HDT-301

RNA

Moderna

mRNA-1273.351

Non Replicating Viral Vector

CyanVac LLC

CVXGA1

Non Replicating Viral Vector

NIAID

ChAdV68-S

Non Replicating Viral Vector

NIAID

SAM-LNP-S

Non Replicating Viral Vector

Vaxart

VXA-CoV2-1

Replicating Viral Vector

Meissa Vaccines Inc

MV-014-212

RNA

Moderna

mRNA-1073

2 trials in 1 country
Protein Subunit

Sanofi/GSK

SP/GSK subunit B.1.351 vaccine

3 trials in 2 countries
VLP

Radboud University

ABNCoV2

4 trials in 3 countries
RNA

Pfizer/BioNTech

Comirnaty Bivalent Original/Omicron BA.4/BA.5

Approved in 33 countries
4 trials in 1 country
RNA

Pfizer/BioNTech

Comirnaty Bivalent Original/Omicron BA.1

Approved in 35 countries
3 trials in 5 countries
RNA

Moderna

Spikevax Bivalent Original/Omicron BA.4/BA.5

Approved in 33 countries
2 trials in 1 country
RNA

Moderna

Spikevax Bivalent Original/Omicron BA.1

Approved in 38 countries
5 trials in 4 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
RNA

Pfizer/BioNTech

BNT162b5 Bivalent (WT/OMI BA.2)

2 trials in 1 country
Protein Subunit

Speransa Therapeutics

PRIME-2-CoV_Beta

RNA

GlaxoSmithKline

CV0501

RNA

Moderna

mRNA-1230

Protein Subunit

Sanofi/GSK

VidPrevtyn Beta

Approved in 30 countries
3 trials in 2 countries

4 Vaccines with Trials in United States of America are No Longer Progressing

Non Replicating Viral Vector

Altimmune Inc

AdCOVID

Replicating Viral Vector

Merck Sharp & Dohme Corp

V590

Replicating Viral Vector

Merck Sharp & Dohme Corp

V591

2 trials in 3 countries
RNA

Sanofi Pasteur

MRT5500

2 trials in 1 country